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Type 2 diabetes is a serious, genetically inﬂuenced disease for which no fully effective treatments are available.
Identiﬁcation of biochemical or regulatory pathways involved in the disease syndrome could lead to innovative
therapeutic interventions. One way to identify such pathways is the genetic analysis of families with multiple affected
members where disease predisposing genes are likely to be segregating.We undertook a genomewide screen (389–395
microsatellite markers) in samples of 835 white, 591 Mexican American, 229 black, and 128 Japanese American
individuals collected as part of the American Diabetes Association’s GENNID study. Multipoint nonparametric
linkage analyses were performed with diabetes, and diabetes or impaired glucose homeostasis (IH). Linkage to
diabetes or IH was detected near markers D5S1404 (map position 77 cM, LOD = 2.80), D12S853 (map position
82 cM, LOD = 2.81) and GATA172D05 (X-chromosome map position 130 cM, LOD = 2.99) in whites, near
marker D3S2432 (map position 51 cM, LOD = 3.91) in Mexican Americans, and near marker D10S1412 (map
position 14 cM, LOD = 2.39) in African Americans mainly collected in phase 1 of the study. Further analyses
showed evidence for interactions between the chromosome 5 locus and region on chromosome 12 containing the
MODY 3 gene (map position 132 cM) and between the X-chromosome locus and region near D12S853 (map
position 82 cM) in whites. Although these results were not replicated in samples collected in phase 2 of the GENNID
study, the region on chromosome 12 was replicated in samples from whites described by Bektas et al. (1999).
Introduction
In 1992, 4.5% of the population of the United States
was diagnosed with type 2 diabetes (Raffel et al. 1996).
Type 2 diabetes is associated with hyperglycemia and
obesity, seldom leads to ketoacidosis, and generally oc-
curs after age 40 years—in contrast to type 1 diabetes,
which is associated with autoimmune destruction of the
b-cells in the pancreas, with a juvenile age of onset
Received December 20, 1999; accepted for publication April 3,
2000; electronically published May 2, 2000.
Address for correspondence and reprints: Dr. Margaret Gelder Ehm,
Glaxo Wellcome, Inc., P.O. Box 13398, Research Triangle Park, NC
27709-3398; E-mail: mge37216@glaxowellcome.com
* Present afﬁliation: Parke-Davis Laboratory for Molecular Genet-
ics, Alameda, CA.
† Present afﬁliation: Pioneer Hi-Bred International, Johnston, IA.
‡ Present afﬁliation: Department of Human Genetics, University of
California–Los Angeles, Los Angeles, CA.
§ Present afﬁliation: National Center for Genome Resources, Sante
Fe, NM.
k See Acknowledgments for a list of GENNID Study Group
members.
 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6606-0016$02.00
(Expert Committee on the Diagnosis and Classiﬁcation
of Diabetes Mellitus 1998). Although the molecular ba-
sis of type 2 diabetes is unknown, it is thought to result
from defects in both insulin action and insulin secretion.
Segregation analysis and twin studies indicate that a ge-
netic component exists, with a recurrence risk to ﬁrst-
degree relatives of ∼3.5 (Rich 1990). In several relatively
uncommon variants of the disease, causative mutations
have been identiﬁed in genes such as the insulin and
insulin-receptor genes (Turner et al. 1995), glucokinase
(Froguel et al. 1993), and the HNF-1a (Yamagata et al.
1996b) and HNF-4a (Yamagata et al. 1996a) transcrip-
tion factors. However, the genetic defects responsible for
the vast majority of cases have not been identiﬁed.
Since type 2 diabetes is thought to be an oligogenic,
multifactorial disease with a substantial environmental
component, a large sample was required to ensure high
power to locate susceptibility genes. The GENNID
(Genetics of NIDDM) study is a multicenter project
sponsored by the American Diabetes Association to col-
lect a large family-based resource, containing multiple
ethnic groups, to be used to identify the genetic com-
ponents of type 2 diabetes (Raffel et al. 1996). We un-
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Table 1
Listing of Individuals Used in Study
Group Whites
Mexican
Americans Blacks
Japanese
Americans Whites 2
Mexican
Americans 2
Families 77 53 65 18 85 64
Individuals 497 365 229 128 338 226
Diabetic individuals (sib pairs) 191 (117) 169 (173) 124 (62) 50 (45) 225 (130) 137 (86)
Diabetic or IHa individuals (sib pairs) 288 (198) 233 (239) 152 (109) 87 (82) 267 (254) 165 (137)
a Impaired glucose homeostasis.
dertook a genome scan of samples collected as part of
the GENNID study to identify chromosomal regions
linked to diabetes and possibly containing diabetes
genes. This paper will describe the results of a genome
scan on 1,783 individuals collected in four ethnic
groups.
Subjects and Methods
Ascertainment of families in the GENNID study in-
cluded two phases. Phase 1 enrolled families with at least
two siblings affected with type 2 diabetes according to
the National Diabetes Data Group criteria (fasting
plasma glucose concentration 1140 mg/dl on more than
one occasion or 2-h and one other time point during an
OGTT that was 1200 mg/dl) (National Diabetes Data
Group 1979). In addition, the families were required to
have at least three available additional ﬁrst-degree rel-
atives and a nondiabetic, ethnically matched control in-
dividual. Phase 2 enrolled families either with at least
two affected siblings and both parents or with one or
no parents and at least two additional siblings.
All individuals collected as part of the GENNID study
completed a family/medical history questionnaire (Raf-
fel et al. 1996), gave fasting blood samples for estab-
lishment of cell lines, insulin, glucose, and lipid mea-
surements, and underwent anthropometric and blood
pressure measurements. Individuals not known to have
diabetes had an oral glucose-tolerance test (Raffel et al.
1996).
The samples analyzed for this study include white,
Mexican American, and black families collected in the
ﬁrst two phases of the GENNID study (Raffel et al.
1996) and Japanese American families collected only in
the ﬁrst phase of the study. Our initial analysis included
the phase 1 white, phase 1 Mexican American, phase
1 Japanese American, and combined phase 1 and 2
black samples. The phase 2 white and Mexican Amer-
ican individuals were used as replication samples. We
did not analyze the phase 1 and 2 black samples sep-
arately because of insufﬁcient numbers in each group.
We applied the American Diabetes Association cri-
teria for the diagnosis of type 2 diabetes, impaired fast-
ing plasma glucose, and impaired glucose tolerance
(Expert Committee on the Diagnosis and Classiﬁcation
of Diabetes Mellitus 1998) to the data collected in the
GENNID study, with the following modiﬁcations: in-
dividuals taking diabetic medications were identiﬁed as
diabetic; conﬁrmation of fasting or 2-h glucose levels
on a subsequent day was not required; and individuals
who were pregnant, were taking glucose-altering med-
ications, were aged !25 years at their diagnosis or exam,
or had a history of diabetes but were not taking diabetes
medications or had normal fasting plasma glucose val-
ues were assigned a diagnosis of “unknown.”
We limited our study to investigating the genome for
linkage to two phenotypes: (a) diabetes, and (b) dia-
betes, impaired fasting glucose (IFG), or impaired glu-
cose tolerance (IGT) (together termed “impaired glucose
homeostasis” [IH]). Diabetes or IH was chosen as a
phenotype, since IFG and IGT may be intermediate
stages in the development of type 2 diabetes (Expert
Committee on the Diagnosis and Classiﬁcation of Di-
abetes Mellitus 1998). Table 1 summarizes the samples
available for study. Table 2 gives a summary of the
clinical characteristics of individuals sampled for phase
1. The characteristics for the phase 2 samples did not
differ appreciably.
Whole-genome polymorphism scans were carried out
at the Marshﬁeld Medical Research Foundation by use
of standard sets of highly informative short-tandem-
repeat polymorphisms (Yuan et al. 1997). The genome
scan consisted of 389–395 markers (screening set 6 for
the phase 1 Mexican Americans, screening set 8 for all
other groups). Additional markers were typed at Glaxo
Wellcome, Inc., to ﬁll gaps in the genome scan, to sat-
urate regions of interest, and to ensure coverage of areas
near candidate genes. The average spacing ranged from
8.2 to 9.0 cM, no gap was greater than 23.5 cM, and
no more than 4 gaps were greater than 20 cM for any
ethnic sample. The average marker heterozygosity for
each sample was ∼0.75.
Inspection of the Mendelian errors over all markers
and the distribution of marker alleles shared identical
by state for each pair of siblings was used to check for
pedigree errors and monozygotic twins (Ehm and Wag-
ner 1998). The pedigree errors were removed and all
other Mendelian errors were eliminated by means of an
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Table 2
Clinical Characteristics of Individuals Sampled
Ethnic Group and Characteristics Mean
Standard
Deviation No.
Whites (n =497, 213 males):
Age at exam 50.73 16.50 472
Age at onset 53.14 13.52 288
BMI 30.43 6.72 271
Fasting glucose (mg/dl) 150.61 64.58 283
Fasting insulin (mU/ml) 14.01 13.26 263
Mexican Americans (n = 365, 135 males):
Age at exam 47.25 16.22 349
Age at onset 49.23 12.82 232
BMI 31.61 8.18 227
Fasting glucose (mg/dl) 175.82 84.11 226
Fasting insulin (mU/ml) 15.71 11.55 216
Blacks (n = 229, 66 males):
Age at exam 51.90 14.56 218
Age at onset 51.02 12.43 152
BMI 33.04 8.69 142
Fasting glucose (mg/dl) 165.48 79.34 149
Fasting insulin (mU/ml) 17.39 21.42 138
Japanese Americans (n = 128, 67 males):
Age at exam 56.17 15.95 125
Age at onset 57.91 13.67 87
BMI 25.84 4.01 84
Fasting glucose (mg/dl) 127.11 35.34 87
Fasting insulin (mU/ml) 8.74 6.91 86
NOTE.—The age of exam was available for all individuals sampled,
while age of onset was only available for individuals whowere diabetic
or exhibited impaired glucose homeostasis. The summary statistics for
body mass index (BMI), fasting glucose and fasting insulin included
only individuals who were diabetic or had impaired glucose homeo-
stasis.
algorithm which identiﬁes individuals for whom setting
their genotype for a particular marker to “missing”
eliminates the errors (R. Idury, personal communica-
tion).
Allele frequencies were estimated for each ethnic sam-
ple by use of all individuals in the sample.Map distances
used for linkage analyses of the white, Japanese Amer-
ican, and black samples were estimated by means of the
phase 1 and 2 white samples. Map distances used for
linkage analyses of theMexican American samples were
estimated with the phase 1 and 2 Mexican American
samples. By use of the Marshﬁeld map as a guide, along
with information from other genetic and physical maps,
a genetic map was created via CRIMAP (Lander and
Green 1987). Additional markers were inserted, and the
map with the most likely order and distance was chosen.
Although the data represent few informative meioses,
when the ﬁnal map was compared to the Marshﬁeld
map there were no signiﬁcant differences noted.
Multipoint nonparametric linkage analysis by means
of affected relative pairs was performed by the Gene-
hunter program (Kruglyak et al. 1996) in conjunction
with Kong and Cox’s modiﬁcation, which calculates
exact likelihoods and reports LOD scores on the basis
of a one-parameter allele-sharing statistic, Zlr, rather
than using the perfect data approximation (Kong and
Cox 1997). The asymptotically normal linkage statistic
(NPL score) reported by GENEHUNTER was used in
interaction analyses.
To investigate the possibility of interaction between
the regions identiﬁed on individual chromosomes fol-
lowing Cox et al. (1999), we incorporated the linkage
evidence for these regions in assessing the evidence for
linkage at other positions. Instead of giving each family
equal weight in Kong and Cox’ approach (Kong and
Cox 1997), families were weighted in three ways, ac-
cording to the NPL score for each family at the position
conditioned upon: (1) families with positive NPL scores
were given a weight of 1, and those with negative NPL
scores were given a weight of 0; (2) families with pos-
itive NPL scores were given a weight of 0, and those
with negative NPL scores were given a weight of 1; and
(3) families with positive NPL scores were given a
weight of NPL/max(NPL), and those with negative NPL
scores were given a weight of 0. P values associated
with the increase in LOD scores were obtained by mul-
tiplying the difference in the weighted LOD scores by
2ln(10) which results in an asymptotically conservative
x2 test with 1 df (Cox et al. 1999). The results represent
exploratory analyses, and consequently the P values
were not adjusted for multiple tests. Correlations be-
tween the family NPL scores from interesting regions
were also calculated.
Results
Our analysis of the pedigree structures by means of the
genotypes generated as part of the genome scan high-
lighted that, in each of the ethnic groups, there were
individuals identiﬁed as males that were likely to be fe-
males (and vice versa), half siblings labeled as full sib-
lings, and pedigree members that showed no relationship
to their supposed pedigree. Given that not all of the
parents were available for study, it was difﬁcult to dis-
tinguish between parental errors and blood- or DNA-
sample mixups. In summary, 24.4% of the families
contained pedigree errors and 2.8% of the families con-
tained errors in which an individual appeared to be un-
related to the rest of the members of the pedigree and
were possibly blood-sample mixups. The percentages
were consistent across all ethnic groups. In total, 212
individuals were removed from the pedigrees to elimi-
nate these errors.
Results of multipoint nonparametric linkage analyses
for diabetes or IH for all phase 1 ethnic samples are
shown inﬁgure 1. LOD scores are plotted versus map
distance for all chromosomes. Five regions were signif-
icant at the level (LOD 1 2.07). Note that theP ! .001
Figure 1 Multipoint linkage analysis results. Results for phase 1 samples for four ethnic groups obtained by analysis of the trait diabetes or impaired glucose homeostasis by multipoint
nonparametric linkage analysis are shown for each chromosome. Subjects from four ethnic groups were genotyped for 389–395 markers. The average spacing was 8.2–9.0 cM.
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results for the diabetes phenotype will be described in
the text, but the data are not shown.
Markers near D3S2432 were linked in Mexican
Americans to diabetes or IH (LOD = 3.91) and diabetes
(LOD = 2.36). Neither result was replicated in the phase
2 Mexican Americans (diabetes or IH: LOD = 0.0028).
Markers near D5S1404 were linked to diabetes or IH
(LOD = 2.8) and to diabetes (LOD = 3.26) in whites.
Neither the phase 2 white samples (diabetes or IH: LOD
= 0.093) nor any other ethnic sample showed linkage
to this region. Markers near D10S1412 were linked to
diabetes or IH (LOD = 2.39) and to diabetes (LOD =
1.06) in African Americans. Markers nearD12S853 (82
cM) were linked to diabetes or IH in whites with a LOD
score of 2.81 and to diabetes with a LOD of 1.91.
Diabetes or IH was also linked to D12S342 (132 cM)
with a LOD score of 1.38, although there was no evi-
dence for linkage of diabetes (LOD = 0.24) to this re-
gion. This region is not signiﬁcant at the level,P = .001
but these results are reported because a similar LOD
score was obtained in the black sample, and it is the
same region reported by Mahtani et al. (1996) to
contain NIDDM2 (MIM 601407). Markers near
GATA172D05 on the X chromosome were linked to
diabetes or IH (LOD = 2.99) and to diabetes (LOD =
2.27) in whites. The phase 2 white samples did not show
linkage to either region on chromosome 12 or the region
on the X chromosome.
As suggested by Cox et al. (1999), we investigated
the evidence for statistical interactions between regions
of linkage by incorporating the linkage evidence with
diabetes or IH for the chromosome 5 region identiﬁed
in the phase 1 whites in assessing the evidence for link-
age on all other chromosomes, using the phase 1 white
samples. Similarly, we incorporated the evidence for
linkage with diabetes or IH for the chromosome 12
(positions 82 cM and 132 cM) and X-chromosome
regions when looking for interactions on all other chro-
mosomes. Any signiﬁcant interactions found were also
assessed in the phase 2 whites. Similarly, we incorpo-
rated the linkage evidence with diabetes or IH for
the chromosome 2 region hypothesized to contain
NIDDM1 (MIM 601283) (Hanis et al. 1996; Bell et al.
1997; Cox et al. 1999) and the chromosome 3 region
in the phase 1 Mexican American samples in assessing
the evidence for linkage on all other chromosomes using
the phase 1 Mexican Americans. There was evidence
for an epistatic interaction between position 130 cM on
chromosome X and position 82 cM on chromosome
12, both linked to diabetes or IH (correlation = .335)
in the phase 1 white samples. Position 130 cM on the
X chromosome gave an original LOD score of 2.99,
but, when families were weighted on the basis of evi-
dence for linkage at 82 cM on chromosome 12, the
LOD score increased to 4.43 ( ). There was alsoP = .010
evidence for an epistatic interaction between position
132 cM on chromosome 12 and position 77 cM on
chromosome 5, both linked to diabetes or IH (corre-
lation = .353) in the phase 1 white samples. Position
132 cM on chromosome 12 gave a LOD score of 1.38
and a weighted LOD score of 2.38 ( ). An ep-P = .032
istatic interaction indicates that the families that are
linked to position 82 cM on chromosome 12 are many
of the same families linked to position 130 cM on the
X chromosome and the families linked to position 132
cM on chromosome 12 are similar to those linked to
position 77 cM on chromosome 5. Neither interaction
was replicated in the phase 2 white samples. No other
regions showed evidence of interactions.
The results highlighted for whites andMexicanAmer-
icans in this study were not replicated in our additional
samples of whites and Mexican-Americans. The results
for the analysis of the phenotype diabetes or IH of the
genome scan completed on the phase 2 samples (data
not shown) of whites and Mexican Americans showed
no multipoint LOD scores signiﬁcant at the .001 level
(LOD 1 2.07) and only four regions signiﬁcant at the
.01 level (LOD 1 1.175). Marker SE30 (0 cM) on chro-
mosome 6 was linked to diabetes or IH in phase 2 whites
(LOD = 2.04). Marker D14S599 (26 cM) was linked
to diabetes or IH in phase 2 whites (LOD = 1.76).
Marker D14S608 (17 cM) was linked to diabetes or
IH in Japanese Americans (LOD = 1.53). Markers
D18S843 (15 cM), D18S535 (50 cM), and D18S851
(63 cM) were linked to diabetes or IH in phase 2 whites
with LOD scores of 1.40, 1.29, and 1.37, respectively.
The results described above and shown inﬁgure 1 in-
cluded data from additional markers typed in three
regions which appeared to show evidence for linkage
in a preliminary analysis of the genome scan in the phase
1 white samples (chromosome 5, position 84 cM; chro-
mosome 9, position 10 cM; chromosome 12, position
88 cM) and in two regions highlighted in the phase 1
Mexican American samples (chromosome 2, position
259 cM; chromosome 3, position 58 cM). The initial
genome scan and gap-ﬁlling markers were ∼10 cM
apart. We selected additional markers with the goal of
obtaining one marker every 5 cM in each of the ﬁve
regions. The LOD scores obtained from analyzing all
of the markers were greater than the LOD scores ob-
tained analyzing only the genome scan markers in four
of the regions, with an average increase of 0.870 LOD
units. In one of the regions, the peak moved 27 cM
centromeric (from position 259 cM to position 232 cM
on chromosome 2 in the Mexican American samples).
In one of the regions the ﬁnal LOD score was !1.0
(chromosome 9 in the white samples). In three of the
regions, the 1–LOD unit support interval obtained from
analyzing all the markers was smaller than that obtained
analyzing only the scan markers: 11 versus 16 cM for
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Table 3
Results of Published Linkages for Type 2 Diabetes
Ethnic Group Sample Peak Marker/Region Trait LOD
White 53 sibling pairs with a history of diabetic
nephropathy (Bowden et al. 1997)
D12S86 Diabetes 1.45
D20S197 Diabetes 1.5
French (white) 133 sibling pairs (Hani et al. 1997) PCK1 (chromosome 20) Diabetes 1.45
White 29 extended families (Elbein et al. 1999) D20S197 Diabetes after 47 2.37
White 42 extended families (Elbein et al. 1999) CRP-APOA2 (chromo-
some 1)
Diabetes (recessive) 4.3
White 26 families (Bektas et al. 1999) D12S375-D12S1052 Diabetes 3.14
Finnish 26 families (Mahtani et al. 1996) D12S1349 Diabetes (stratiﬁed on 30-
min insulin)
3.3
Finnish 477 families (Ghosh et al. 1999) 20p Diabetes 2.06
Mexican American 330 sibling pairs (Hanis et al. 1996; Bell
et al. 1997; Cox et al. 1999)
D2S125 Diabetes 4.03
CYP19 (chromosome 15) Diabetes (weighted) 4.00
Mexican American 27 extended families (Duggirala et al.
1999)
D3S1566-GATA128C02 Diabetes onset age 2.51
Diabetes 2.67
D4S1615 Diabetes 1.94
D9S288-D9S925 Diabetes onset age 2.06
Diabetes 2.38
D10S587 Diabetes onset age 3.75
Diabetes 2.88
Pima Indian 264 nuclear families (Hanson et al. 1998) D6S1009-D6S1003 Age-adjusted diabetes 1.39
D9S299-D9S2026 Age-adjusted diabetes 1.22
D11S4464-D11S912 Age-adjusted diabetes 1.66
D1S127 Diabetes before age 25 years 4.1
D7S1799 Diabetes 1.8
chromosome 3 in the Mexican American, 17 versus 77
cM for chromosome 5 and 12 versus 19 cM for chro-
mosome 12 in the white samples).
Discussion
The GENNID study is unique, because samples from
four distinct ethnic groups were ascertained, diagnosed,
and genotyped and the resulting data was analyzed in
a uniform and consistent manner. The individuals stud-
ied were sampled from outbred populations at eight cen-
ters throughout the United States. Consequently, the af-
fected individuals are likely to be broadly representative
of patients with type 2 diabetes, in contrast to studies
in isolated populations, which may represent less com-
mon forms of disease. The phenotypes used for analysis
include diabetes (using 1998 ADA criteria) and a broad
diabetes phenotype, diabetes or impaired glucose ho-
meostasis, which includes individuals with diabetes, im-
paired fasting glucose, or impaired glucose tolerance.
Linkage analysis results obtained with these phenotypes
(particularly diabetes or impaired glucose homeostasis)
represent genes that confer susceptibility to common di-
abetic and prediabetic phenotypes. Although the GEN-
NID study as a whole (phases 1 & 2) includes more
families than many of the published reports, the number
of families in each ethnic group is modest.
A number of authors have reported linkages to type
2 diabetes, each with varying levels of evidence (table
3). There are two reports of linkage on chromosome 3
in Mexican Americans. Hanis et al. (1996) and Bell et
al. (1997) show nominal evidence (LOD 10.59) for a
region around D3S2452 in their sample of Mexican
Americans. This region is 20 cM centromeric to the
marker (D3S2432) showing the peak LOD score in the
GENNID Mexican Americans, but it overlaps substan-
tially with the peak. Duggirala et al. (1999) show evi-
dence for linkage of age of diabetes onset (LOD = 2.51)
and diabetes (LOD = 2.67) to a region on 3p inMexican
Americans. However, their map appears to be signiﬁ-
cantly different than ours, and the region that they re-
port is 55 cM centromeric (map position 108 cM on
our map) to D3S2432 (Duggirala et al. 1999). Hanis et
al. and Bell et al. results in Mexican Americans may
replicate the result we report on chromosome 3, but the
linkage reported by Duggirala et al. appears to be too
far away.
Other authors have also provided replication for our
results on chromosome 12. The ﬁrst region on chro-
mosome 12 (markers near D12S853: 82 cM) overlaps
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with the region identiﬁed by Bektas et al. (1999) as
linked to type 2 diabetes among early-onset white fam-
ilies with apparent autosomal dominant inheritance of
diabetes (LOD = 3.14 at D12S1052, corresponding to
map position 68 cM on our map ). The second region,
∼50 cM telomeric (D12S342) to the ﬁrst, corresponds
to the proposed location of NIDDM2 (Mahtani et al.
1996) and contains the MODY3 gene (MIM 600496)
(Yamagata et al. 1996b), HNF-1a. Sequencing of the
protein-coding exons and ﬂanking intronic sequences of
HNF-1a of unrelated Mexican Americans (60 diabetic
patients and 14 controls) and whites (69 diabetic
patients and 19 controls) from the GENNID sample
revealed no known or novel mutations (E. Lai, un-
published data), making it unlikely that HNF-1a is re-
sponsible for these results. Note that the black samples
also show linkage to diabetes or impaired glucose ho-
meostasis at position 132 cM (D12S342) with a LOD
score of 1.40. This is the only location in the entire
genome scan for which two or more ethnic groups show
linkage to the same region with LOD scores signiﬁcant
at the level. Given the distance between the twoP = .01
regions of linkage on chromosome 12, the independent
evidence for replication of these linkages, and the fact
that the regions linked to D12S853 and D12S342 ap-
pear to be involved in epistatic interactions with genes
on different chromosomes, it seems likely that there are
at least two diabetes-susceptibility genes on chromo-
some 12.
Our results on chromosome 2 do not convincingly
replicate the linkage identiﬁed by Hanis et al. (1996)
and Bell et al. (1997) (putative disease gene named
NIDDM1). We obtained a LOD score of 0.88 for
D2S125 and a LOD score of 1.66 for D2S362 (30 cM
centromeric) in Mexican Americans. Some of the fam-
ilies studied by Hanis et al. (1996) and Bell et al. (1997)
are also included in the GENNID collection, so it is not
surprising to ﬁnd modest evidence for linkage near the
NIDDM1 gene at D2S125, and, therefore, this may not
represent an independent replication. It seems unlikely
that the higher LOD score we see at D2S362, 30 cM
from D2S125, could also be due to the NIDDM1 gene.
The chromosome 3 linkage region and the one on
chromosome 5 are relatively gene-rich and contain ob-
vious candidate genes. GNAI2 (MIM 139360), encod-
ing Gia2, is the most interesting candidate for the chro-
mosome 3 region. Gia2 knock-out mice are severely
insulin resistant (Moxham and Malbon 1996), whereas
mice overexpressing a constituitively active mutant (co-
don 205GlnrLeu) in liver and skeletal muscle exhibited
enhanced glucose tolerance compared with controls
(Chen et al. 1997). The chromosome 5 linkage region
contains three candidate genes of interest. PIK3R1
(MIM 171833), which encodes the p85a regulatory
subunit of PI3′-kinase, is of interest, since mice lacking
this subunit exhibit increased insulin sensitivity and
moderate hypoglycemia, presumably because of the
compensatory overexpression of its alternately spliced
p50a variant (Terauchi et al. 1999). Hansen et al.
(1997) and Kawanishi et al. (1997) detected a codon
326MetrIle variant in Danish and Japanese populations,
respectively. The observed allele frequency did not differ
between affected and unaffected individuals in either
population. Hansen et al. did note, however, that in-
dividuals homozygous for the Ile allele exhibited re-
duced whole-body glucose disposal and intravenous
glucose-disappearance constant. Hansen et al. (1997)
also reported three silent polymorphisms in codons 261
(CrT), 663 (TrG) and 810 (ArG). Two additional
genes in this region also merit comment. The ISL1
(MIM 600366) gene encodes a tissue-speciﬁc transcrip-
tion factor that regulates pancreas development and ex-
pression of the insulin gene. Tests for linkage of ISL1
with diabetes were negative in Nigerian and African
American populations (Tanizawa et al. 1994) and a
white French population (Riggs et al. 1995). The fol-
listatin gene, FST (MIM 136470), which regulates the
relative proportion of endocrine and exocrine tissue in
the pancreas, also lies within this region on chromosome
5. Urbanek et al. (1999) recently reported evidence of
linkage between FST and PCO1 (MIM 184700), poly-
cystic ovary syndrome, which shares many features with
type 2 diabetes, especially insulin resistance (Urbanek
et al. 1999). To our knowledge no tests of linkage be-
tween FST and diabetes related phenotypes have been
conducted to date. By contrast to the regions of chro-
mosome 3 and chromosome 5 that are linked to dia-
betes, the two regions of linkage on chromosome 12
are relatively gene poor and, with the exception already
noted of HNF-1a near the linkage peak at 132cM, do
not contain obvious candidates. The linkage region on
the X chromosome is a similarly gene-poor region.
As described in the results section, we chose to type
additional markers in three regions in the phase 1 white
samples and two regions in the phase 1 Mexican Amer-
ican samples. The regions were selected on the basis of
the strength of the LOD score in the region and other
published reports concerning the region. Given the re-
sults that we report for these ﬁve regions, typing ad-
ditional markers in regions showing suggestive or sig-
niﬁcant evidence for linkage may increase the evidence
for linkage and narrow the 1-LOD-unit support inter-
val. In two of these regions (chromosomes 5 and 12 in
the whites), we typed additional markers so that the
average distance between markers was 2 cM. The evi-
dence for linkage derived from these maps was very
similar to that derived from markers spaced ∼5 cM
apart, suggesting that typing markers !5 cM apart may
have limited utility for linkage mapping.
The results obtained for the phase 1 samples of the
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GENNID study generally were not replicated in the
other ethnic groups. This may be because the ethnic
groups have very distinct population histories and, in
each population, different genes are responsible for dis-
ease susceptibility. Results shown for the phase 1 sam-
ples were not replicated in the phase 2 samples. This
may be due to the fact that the ascertainment criteria
in the second phase resulted in collecting mostly sibling
pairs, in contrast to the more extended families (con-
taining sibling pairs) collected in the ﬁrst phase (see
Methods). Of 1,568 relative pairs with DNA in the
phase 1 white sample, 884 pairs represent ﬁrst-degree
relative relationships, and 636 pairs represent second-
degree relationships. For the phase 2 white sample, 531
of the 570 possible pairs represent ﬁrst-degree relation-
ships and 36 represent second-degree relationships. In
the phase 1 Mexican American sample, 663 and 554
of the 1,252 possible pairs represent ﬁrst-degree and
second-degree relationships, respectively. In the phase 2
Mexican American sample, 325 and 5 of the 338 pos-
sible pairs represent ﬁrst- and second-degree relation-
ships, respectively. It is also possible that the lack of
replication in the phase 2 samples is because of the
number of genes likely to be involved in the etiology of
diabetes and the difﬁculties of replicating results with-
out very large sample sizes (Suarez et al. 1994). None-
theless, in our analyses, the more extended families pro-
vided more information and ﬂexibility. It has been our
experience that linkage results are rarely replicated in
other populations, leading us to the conclusion that per-
haps very large family collections are more desirable
than replication datasets that are limited largely to sib-
ling pairs. In addition to large numbers of families, it
is critical that samples suitable for ﬁne mapping (in the
same population) also be collected in conjunction with
the initial family resource. This could be accomplished
by collecting unaffected siblings, parents, or unrelated
control individuals.
While none of the studies undertaken to date is likely
to have the power to identify all diabetes genes (Suarez
et al. 1994), this study identiﬁed linkages on chromo-
some 3 and 12 that were highlighted by others. Linkage
on chromosome 3 (LOD score = 3.91) is signiﬁcant at
the most stringent level (Lander and Kruglyak 1995)
and linkages on chromosome 5, 12, and X are sugges-
tive. Further, these results have identiﬁed interactions,
although unreplicated ones, between these linkages,
which, according to Cox et al. (1999), provides addi-
tional evidence that loci from these regions contribute
to disease susceptibility. Although the biological model
underpinning the evidence for epistatic interactions be-
tween potential disease-susceptibility loci on chromo-
somes X and 12 and 5 and 12 is not readily apparent,
these interactions may prove useful in identifying the
disease-susceptibility genes. The strength of the evidence
for linkage to broad diabetes phenotypes and the ad-
ditional reports in the literature suggesting these regions
are linked in other populations give us conﬁdence that
these regions harbor genes that are involved in type 2
diabetes.
This study represents a collaborative effort between
industry, academia, and a nonproﬁt organization (the
American Diabetes Association). Given the likely need
for large and diverse family collections to identify and
conﬁrm linkages to type 2 diabetes and other genetically
complex diseases, this type of collaboration could
provide a model for further work. The genotype and
phenotype data described in this paper are publicly
available by request from the American Diabetes
Association.
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